Arantes-Oliveira, NunoLückenbach, Arthur Carl Ulrich2025-01-272025-01-272024-06-122024-05-17http://hdl.handle.net/10362/177962TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of jellyfish collagen across social, environmental, and ecological dimensions, offering a superior alternative to bovine- and porcine-based collagen products for wound healing. This paper introduces the product with its scientific work, analyses the stakeholders and the competitive environment of the product and presents a detailed business model. It then outlines the funding requirements, targeted sources of funding and exit strategies.engBiotechnologyBiomedical innovationBusiness strategyIntellectual propertyPharmaceuticalCompetitive analysisFundingUlcersWound healingChronical woundsJellyfishMarine collagenVenture capitalIntrapreneurshipEntrepreneurshipmaster thesis203724496